|
|
|
|
| LEADER |
00000cam a22000004a 4500 |
| 001 |
5136177 |
| 003 |
ICU |
| 005 |
20050209135400.0 |
| 008 |
020605s2003 njua b 001 0 eng |
| 010 |
|
|
|a 2002068918
|
| 020 |
|
|
|a 089603982X (alk. paper)
|
| 040 |
|
|
|a DNLM/DLC
|c DLC
|d DLC
|d OCoLC
|d OrLoB-B
|
| 042 |
|
|
|a pcc
|
| 050 |
0 |
0 |
|a RC268.42
|b .O5196 2003
|
| 060 |
1 |
0 |
|a QZ 202
|b O5414 2003
|
| 082 |
0 |
0 |
|a 616.99/4042
|2 21
|
| 245 |
0 |
0 |
|a Oncogene-directed therapies /
|c edited by Janusz Rak.
|
| 260 |
|
|
|a Totowa, N.J. :
|b Humana Press,
|c c2003.
|
| 300 |
|
|
|a xiii, 486 p. :
|b ill. (some col.) ;
|c 26 cm.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|0 http://id.loc.gov/vocabulary/contentTypes/txt
|
| 337 |
|
|
|a unmediated
|b n
|2 rdamedia
|0 http://id.loc.gov/vocabulary/mediaTypes/n
|
| 338 |
|
|
|a volume
|b nc
|2 rdacarrier
|0 http://id.loc.gov/vocabulary/carriers/nc
|
| 440 |
|
0 |
|a Cancer drug discovery and development
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 505 |
0 |
0 |
|g Pt. I.
|t Basic Concepts in Oncogene Research --
|g 1.
|t Genetic Basis of Cancer Progression /
|r Susan J. Done and Jeremy A. Squire --
|g 2.
|t The Molecular Basis of Chromosomal Instability in Human Cancer Cells /
|r Daniel P. Cahill --
|g 3.
|t Signal Transduction Networks: Ras as a Paradigm /
|r Frank McCormick --
|g 4.
|t Oncogenic Receptor Tyrosine Kinases /
|r Mark H. Kirschbaum, Mina D. Marmor and Yosef Yarden --
|g 5.
|t Ras-Mediated Deregulation of Gene Expression and Contribution to Oncogenesis /
|r Gretchen A. Murphy and Channing J. Der --
|g 6.
|t The Interplay Between Tumor Suppressor Genes and Oncogenes in Tumorigenesis /
|r Eric C. Holland --
|g 7.
|t Genetic Basis of Altered Responsiveness of Cancer Cells to Their Microenvironment /
|r Amato J. Giaccia --
|g Pt. II.
|t The Functional Impact of Oncogene Expression on Cancer Cells - Therapeutic Implications --
|g 8.
|t Deregulation of Cell Cycle Progression by Oncogenic Transformation /
|r Marcelo L. Rodriguez-Puebla, Adrian M. Senderowicz and Claudio J. Conti --
|g 9.
|t Oncogenes as Regulators of Cell Survival: The Role of Oncogenes and Tumor Suppressor Genes in the Induction of Resistance to Anoikis and Hypoxia /
|r Kirill Rosen and Jorge Filmus --
|g 10.
|t Oncogenes and Tumor Angiogenesis /
|r Janusz Rak and Robert S. Kerbel --
|g 11.
|t Oncogenes as Therapeutic Targets to Prevent Metastasis /
|r Ann F. Chambers and Hemanth J. Varghese --
|g 12.
|t The Impact of Oncogenes on Tumor Maintenance /
|r Senji Shirasawa and Takehiko Sasazuki --
|g 13.
|t Primary and Secondary Events in Oncogene-Driven Tumor Development: Lessons from Transgenic Model Systems /
|r Michaela Herzig and Gerhard Christofori --
|g Pt. III.
|t Oncogenes as Targets for Anticancer Therapy In Vivo --
|g 14.
|t Targeting Oncogenes in Hematopoietic Malignancies /
|r Michael E. O'Dwyer and Brian J. Druker --
|g 15.
|t Clinical Evaluation of Agents Targeting Epidermal Growth Factor Receptor (EGFR) in Cancer /
|r Edward H. Lin and James L. Abbruzzese --
|g 16.
|t Inhibition of the HER-2/neu Oncogene: A Translational Research Model for the Development of Future Targeted Therapies /
|r Gottfried E. Konecny, Jane Arboleda, Dennis J. Slamon and Mark Pegram --
|g 17.
|t Farnesyltransferase Inhibitors as Anticancer Agents /
|r Adrienne D. Cox --
|g 18.
|t Targeting Oncogenic Signaling Pathways in Human Astrocytomas /
|r Gelareh Zadeh and Abhijit Guha --
|g 19.
|t Targeting Oncogenes in Pediatric Malignancies /
|r Giannoula Klement and Robert S. Kerbel --
|g 20.
|t Inhibiting Signal Transduction as an Approach to Radiosensitizing Tumor Cells /
|r Eric J. Bernhard, Anjali K. Gupta, Elizabeth Cohen-Jonathan, Ruth J. Muschel, Stephen M. Hahn and W. Gillies McKenna --
|g 21.
|t Oncogenes as Targets for Cancer Vaccines /
|r Samir N. Khleif and Joseph A. Lucci III --
|g 22.
|t Bcl-2 Antisense Oligonucleotides Therapy for Cancer: Targeting the Mitochondria /
|r Finbarr E. Cotter and Dean A. Fennell.
|
| 650 |
|
0 |
|a Oncogenes.
|0 http://id.loc.gov/authorities/subjects/sh85094721
|
| 650 |
|
0 |
|a Cancer
|x Molecular aspects.
|0 http://id.loc.gov/authorities/subjects/sh89006610
|
| 650 |
|
0 |
|a Cancer
|x Gene therapy.
|0 http://id.loc.gov/authorities/subjects/sh92005201
|
| 650 |
|
0 |
|a Biological response modifiers.
|0 http://id.loc.gov/authorities/subjects/sh85014187
|
| 650 |
1 |
2 |
|a Oncogenes.
|
| 650 |
2 |
2 |
|a Neoplasms
|x therapy.
|
| 650 |
|
7 |
|a Biological response modifiers.
|2 fast
|0 http://id.worldcat.org/fast/fst00832312
|
| 650 |
|
7 |
|a Cancer
|x Gene therapy.
|2 fast
|0 http://id.worldcat.org/fast/fst00845367
|
| 650 |
|
7 |
|a Cancer
|x Molecular aspects.
|2 fast
|0 http://id.worldcat.org/fast/fst00845397
|
| 650 |
|
7 |
|a Oncogenes.
|2 fast
|0 http://id.worldcat.org/fast/fst01045729
|
| 700 |
1 |
|
|a Rak, Janusz.
|0 http://id.loc.gov/authorities/names/n2002134947
|1 http://viaf.org/viaf/311810218
|
| 901 |
|
|
|a ToCBNA
|
| 903 |
|
|
|a HeVa
|
| 903 |
|
|
|a Hathi
|
| 035 |
|
|
|a (OCoLC)50002208
|
| 929 |
|
|
|a cat
|
| 999 |
f |
f |
|i 94bb96c8-4333-51c6-a1ff-3e9be7fb9408
|s 5eea2d01-f251-5ef0-9fe8-314397bdb362
|
| 928 |
|
|
|t Library of Congress classification
|a RC268.42 .O5196 2003
|l ASR
|c ASR-SciASR
|i 5006555
|
| 927 |
|
|
|t Library of Congress classification
|a RC268.42 .O5196 2003
|l ASR
|c ASR-SciASR
|e WAGN
|e CRERAR
|b 65530003
|i 7669490
|
